EGEdson Guzmán-Calderón

Edson Guzmán-Calderón

*This is an algorithmically generated author record based on publicly available information.

Edson Guzmán-Calderón has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison between the different suction techniques for eus-guided tissue acquisition in pancreatic diseases and other gastrointestinal lesions: a systematic review and meta-analysis of randomized controlled trials

    by Edson Guzmán-Calderón, Carlos Díaz-Arocutipa, Augusto Vera, José Ramón Aparicio

    Objectives: Endoscopic ultrasound–guided fine-needle aspiration/biopsy (EUS-FNA/B) is pivotal for diagnosing solid pancreatic lesions and other gastrointestinal (GI) masses. Multiple suction strategies are used to optimize tissue acquisition. Currently, their comparative performance remains uncertain. Materials and methods: We searched PubMed, Medline, Cochrane, and Ovid through July 2025 for English-language. RCTs comparing four suction methods during EUS-FNA/B of solid pancreatic or other GI lesions. Primary outcomes were specimen tissue adequacy and diagnostic accuracy. Results: Twenty-two RCTs encompassing 2,922 patients were included; pancreas was the sampled organ in 81% of cases, with the remainder primarily lymph nodes. Across 20 RCTs reporting adequacy, WS was associated with lower specimen adequacy than no suction (RR 0.88, 95% CI 0.77-0.99). WS likewise yielded lower diagnostic accuracy than no suction (RR 0.89, 95% CI 0.82-0.97). In head-tohead comparisons versus DS, differences among DS, SSP/capillarity, no suction, and WS were generally nonsignificant. Ranking analyses favoured no suction as the top performer and consistently placed WS lowest for both adequacy (p=0.92 vs 0.06, respectively) and accuracy (p=0.96 vs 0.04, respectively). In the needle-stratified analysis, results were concordant: with 22-G devices, WS showed lower adequacy (RR 0.86, 95% CI 0.74-0.99) and lower accuracy (RR 0.86, 95% CI 0.77-0.95) than with no suction. Conclusions: This meta-analysis suggests that wet suction may be associated with lower diagnostic yield and reduced tissue adequacy compared to no suction, especially with 22G needles. However, outside of these comparisons, no consistent differences were observed among the other techniques. Future comparative studies with standardized methodology and stricter control of confounding factors are needed.

  • Covered Versus Uncovered Metal Stents for the Drainage of the Malignant Distal Biliary Obstruction With ERCP

    by Gerly Edson Msc Guzmán-Calderón, Juan Chirinos, Carlos Díaz-Arocutipa, Eduardo Vesco, Jorge Huerta-Mercado, Hugo Cedrón, Dora Montezuma, Gunther Poppele, José Ramón Aparicio

    Introduction and Aim: Unresectable malignant distal biliary obstruction is a condition that should be treated with drainage and clearance of the biliary duct. self-expanded metal stents (SEMS) are known to be better and more effective than plastic stents because the patency is longer. The actual evidence is insufficient to recommend if it is better the use of SEMSu over SEMSc or vice versa for the drainage of the malignant distal biliary obstruction during ERCP. We performed a systematic review and meta-analyses to demonstrate if exists superiority between one or other type of SEMS performed by ERCP. Materials and Methods: We conducted a systematic review in different databases, such as PubMed, Cochrane, Medline, and OVID database. A search was made of all studies published up to May 2023. Results: Seven studies were analyzed. A total of 1070 patients were included. Of the total of patients, 48.9% were male. The cumulative stent patency, the failure rate, the survival probably and the adverse events rate, were similar between SEMSc and SEMSu groups. The stent migration rate was higher in the SEMSc group (RR=2.34 [95% CI: 1.35-4.08]). The tumor overgrowth was higher in the SEMSc group (RR=2.05 [95% CI: 1.13-3.72]). The tumor ingrowth was higher in the SEMSu group (RR=0.25 [95% CI: 0.11-0.61]). Conclusions: The conclusions of our study show that there are no differences between the use of uncovered SEMS and covered SEMS for palliative treatment of distal biliopancreatic obstructions, and it has no impact on mortality or patient survival. New functional studies regarding the type of stent cover, radial force or length thereof are required.


  • Impact of biliary stents in the performance of the EUS-guided tissue acquisition: A systematic review and meta-analysis

    by Edson Guzmán-Calderón, Alfonso Chacaltana, Carlos Díaz-Arocutipa, Ramiro Díaz, Ronald Arcana, José Ramón Aparicio

  • Open Access

    Common bile duct polyp: an infrequent cause of jaundice and biliary obstruction

    by Gerly E. Guzmán-Calderon, Carlos Huaraca, Brandon Bravo, Joseph Arzapalo

    The most common etiology of common bile duct (CBD) obstruction is bile duct stones; less common causes include biliary polyps and intraductal papillary neoplasm of the bile duct (IPNB). Initially described by Nakamura et al. [1] in 2010, IPNB is defined as a pedunculated mass with intraluminal growth exhibiting significant malignant potential that can subsequently lead to cholangiocarcinoma. We present the case of a 75-year-old woman with a history of jaundice and mild abdominal pain. Computed tomography and magnetic resonance cholangiopancreatography showed circumferential thickening of the proximal CBD and left hepatic duct ([Fig. 1] , [Fig. 2]). Liver function tests confirmed a cholestatic pattern, with total bilirubin of 7.4 mg/dL, direct bilirubin of 5.3 mg/dL, alkaline phosphatase of 475 IU/L, and normal CA 19.9 level. Cholangioscopy revealed a single whitish papillary mass with a regular surface, located between the proximal CBD and left hepatic duct, obstructing approximately 80% of the biliary lumen ([Video 1]). Multiple samples were obtained using SpyBite forceps (Boston Scientific, Marlborough, Massachusetts, USA). Histological analysis confirmed the presence of an IPND with high grade dysplasia ([Fig. 3] , [Fig. 4]). The patient underwent left hepatectomy. The surgical specimen demonstrated a 17-mm lesion with biliopancreatic epithelium, involvement of the left hepatic duct, and no evidence of invasive carcinoma ([Fig. 4]). Biliary polyps are classified as IPNBs. Given their potential to cause obstructive jaundice and cholangitis, as well as a high malignant potential, IPNBs must be treated surgically [2] [3]. Our case underscores the value of performing cholangioscopy with targeted biopsies for the assessment and characterization of CBD tumors. Endoscopy_UCTN_Code_TTT_1AR_2AD Article published online: 08 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Multiple ulcerated submucosal masses in the gastrointestinal tract: a rare presentation of metastatic cutaneous malignant melanoma

    by Gerly Edson Guzman-Calderon, Luis Marin, Fiorella Monge, Jaime Campos, Jose Rivera, Ronald Mendoza

    Malignant melanoma is the most common metastatic tumor of the gastrointestinal (GI) tract [1]; it is rarely a primary tumor in the GI tract. Malignant melanoma is more frequently identified in the anus and rectum (31% and 22%, respectively), but it can also be found in the esophagus (6%), stomach (3%), small intestine (2%), and large intestine (1%), as well as in the oronasopharynx (35%) [2]. We report the case of a 71-year-old woman with a history of nodular malignant melanoma of the right leg, which had been surgically resected 3 years previously. She presented to us with an episode of upper GI bleeding, with melena and hematemesis. Laboratory tests showed a hemoglobin of 6.6 g/dL with a mean cell volume (MCV) of 75 fL, and an albumin of 3.2 mg/dL; liver function tests and coagulation tests were normal. An upper GI endoscopy was performed, and multiple gastric ulcerated submucosal masses were found ([Fig. 1]), in addition to other nodular lesions on the posterior aspect of the duodenal bulb and in the esophageal introitus ([Fig. 2]). We decided to perform endoscopic mucosal resection (EMR) of one of the gastric masses ([Fig. 3]; [Video 1]). A lesion with similar features was later found at the ileocecal valve during a colonoscopy ([Fig. 4]). Histology showed that all of the lesions were malignant epithelioid neoplasms with atypia; immunohistochemical analyses showed positivity for S100(+) and Melan A(+), which is compatible with metastatic malignant melanoma ([Fig. 5]) Nowadays, it is essential to consider that malignant melanoma is the most common metastatic tumor of the GI tract. Endoscopically, melanoma metastases to the stomach are classified into three types: ulcerated melanotic nodules on normal rugae; ulcerated submucosal masses; and pigmented mass lesions with necrosis [1] [3] [4]. In this case, the lesions found corresponded with the second type. In conclusion, this case demonstrates a rare presentation of metastatic melanoma, because it was affecting the entire GI tract. It is essential to consider these types of lesions as part of the spectrum of malignant melanoma. They are sometimes asymptomatic but unfortunately the prognosis is quite gloomy if they are found. Endoscopy_UCTN_Code_TTT_1AO_2AG Article published online: 01 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Impact of biliary stents in the performance of the EUS-guided tissue acquisition: A systematic review and meta-analysis

    by Edson Guzmán-Calderón, Alfonso Chacaltana, Carlos Díaz-Arocutipa, Ramiro Díaz, Ronald Arcana, José Ramón Aparicio

  • Open Access

    Guía de práctica clínica para el manejo de la pancreatitis aguda en el seguro social del Perú (Essalud)

    by Edson Guzmán-Calderón, Wilen Horacio Suárez Ale, Lesly Chávez-Rimache, Luygy Zavaleta Jara, Miguel José Díaz Gonzales, Wilmer Gustavo Quiroga Purizaca, Marco Terán Choquehuanca, Victor Lizarzaburu Rodríguez, Sandra Graciela Vargas Márquez, Hector Juarez Granda, et al.

    El presente artículo resume la guía de práctica clínica (GPC) para el manejo de la pancreatitis aguda en el Seguro Social del Perú (EsSalud). Su objetivo es proveer recomendaciones clínicas basadas en evidencia para el manejo de la pancreatitis aguda en EsSalud. Se conformó un grupo elaborador de la guía (GEG) que incluyó médicos especialistas y metodólogos. El GEG formuló 7 preguntas clínicas a ser respondidas por la presente GPC. Se realizó búsquedas sistemáticas de revisiones sistemáticas y –cuando fue considerado pertinente– estudios primarios en PubMed durante el 2022. Se seleccionó la evidencia para responder cada una de las preguntas clínicas planteadas. La certeza de la evidencia fue evaluada usando la metodología Grading of Recommendations Assessment, Development, and Evaluation (GRADE). En reuniones de trabajo periódicas, el GEG usó la metodología GRADE para revisar la evidencia y formular las recomendaciones, los puntos de buenas prácticas clínicas y flujogramas correspondientes. Finalmente, la GPC fue aprobada con Resolución N° 105-IETSI-ESSALUD-2022. La presente GPC abordó 7 preguntas clínicas sobre fluidoterapia, momento de inicio de nutrición enteral, analgesia, tipo de nutrición, tratamiento antibiótico y quirúrgico. En base a dichas preguntas se formularon 8 recomendaciones (1 fuerte y 7 condicionales), 13 BPC, y 1 flujograma. El pres as en evidencia de la GPC para el manejo de la pancreatitis aguda en EsSalud.


  • Open Access

    EUS-Guided gallbladder drainage vs percutaneous transhepatic drainage in patients with acute cholecystitis: a systematic review and meta-analysis

    by Edson Guzmán-Calderón, Alfonso Alfonso Chacaltana1, Carlos Díaz-Arocutipa, Ramiro Díaz, Ronald Arcana, José Ramón Aparicio

    Occasionally, cholecystectomy is not possible because the patient is not suitable for surgery, and non-operative management should be performed. In these patients, the non-operative management can be through the percutaneous transhepatic gallbladder drainage (PTGBD) or the endoscopic gallbladder drainage. We decided to compare the efficacy and safety of PTGBD and EUS-GBD in the non-operative management of patients with acute cholecystitis. We conducted a systematic review in different databases, such as PubMed, OVID, Medline, and Cochrane Databases. This meta-analysis considers studies published until September 2021. Six studies were selected (2 RCTs). These studies included 749 patients. The mean age was 72.81 ±7.41 years, and males represented 57.4%. EUS-GBD technical success was lower than PTGBD (RR, 0.97; 95% CI, 0.95-0.99), whereas clinical success and adverse events rates were similar in both groups. Twenty-one deaths were reported in all six studies. The global mortality rate was 2.80%, without differences in both groups (2.84% and 2.77% in the EUS-GBD group and the PTGBD groups, respectively). EUS-GBD and PTGBD were successful techniques for gallbladder drainage in patients with acute cholecystitis who are non-tributary for surgery. EUS-GBD has a similar clinical success rate and a similar adverse events rate in comparison to PTGBD. The high technical success and the low adverse events rate of the EUS approach to gallbladder make this technique an excellent alternative for patients with acute cholecystitis who cannot be undergoing surgery.


  • Open Access

    Endoscopic ultrasound-guided portal pressure gradient measurement

    by Edson Guzmán-Calderón, Belén Martínez-Moreno, José Ramón Aparicio

    A 55-year-old man with a past medical history of chronic liver disease and small esophageal varices on upper gastrointestinal endoscopy underwent endoscopic ultrasound-guided portal pressure gradient (EUS-PPG) measurement. The materials that were used to perform the procedure were: a pressure monitor, a pressurization bag, a 22G fine-needle aspiration (FNA) needle, and heparinized saline. The system was zeroed at the right mid-axillary line ([Fig. 1]). A curvilinear array echoendoscope (GF-UCT180, Olympus, Tokyo, Japan) that allowed color Doppler imaging was placed in the stomach to visualize the hepatic vascular anatomy. The primary step in the technique for EUS-PPG measurement is to identify the liver landmarks: the inferior vena cava (IVC) and the portal vein. These landmarks allow the identification of the liver segments I, VII, and VIII ([Fig. 2 a]). Following this, a counterclockwise movement must be made with the endoscope to identify the left hepatic vein (LHV), which is another important landmark in recognizing segments II and III, which are seen above and below the LHV, respectively ([Fig. 2 b]). The LHV is the initial structure in which the puncture must be performed. It is punctured with a 22G FNA needle ([Fig. 2 c]), and 1 mL of heparinized saline is flushed into the vein, with the pressure being observed on the monitor. An alternative when puncture of the LHV is not possible is puncture of the IVC, which theoretically is more accessible because of its larger size. Lastly, it is necessary to search for the portal vein, which has a fish-eye appearance. The portal vein is another important landmark in identifying liver segments III and IVb. The technique of portal vein puncture ([Fig. 2 d]) is the same as for the LHV and IVC. It is essential to note that three punctures with three measurements should be performed in each vein (three in the LHV or IVC and three in the portal vein) ([Video 1]). To calculate the pressure in each vein, it is necessary to take the mean of the values for that vein. The PPG is the result of the difference between the pressure of the LHV or IVC and the pressure in the portal vein. Video 1 An endoscopic ultrasound-guided portal pressure gradient (PPG) measurement is performed, with identification of the hepatic landmarks, puncture of the left hepatic vein (or inferior vena cava as an alternative) and portal vein, giving a PPG of 19 mmHg, which represents portal hypertension. Currently, the hepatic venous pressure gradient (HVPG) measurement is the main option for determining portal pressure [1], but it is indirect and the method is not free of complications. In contrast, EUS-PPG is a direct measurement and the results are similar to those for HVPG, with excellent consistency between the methods [2] [3]. The use of the 22G FNA needle seems safer than the use of a 25G FNA needle, which other authors have used. Endoscopy_UCTN_Code_TTT_1AS_2AG Article published online: 24 August 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Hemorragia digestiva alta no variceal

    by Jorge Huerta-Mercado Tenorio, Edson Guzmán-Calderón, Eduardo Vesco-Monteagudo

    La hemorragia digestiva alta es el diagnóstico gastroenterológico más frecuente que requiere hospitalización. Un estudio poblacional en países occidentales reporta una incidencia de 103 casos por 100 000 adultos por año y una mortalidad de 14%. Se esperaría que la incidencia esté disminuyendo debido a las mejoras en el campo del tratamiento, sin embargo la mortalidad se mantiene estable, y esto debido al aumento de la hemorragia digestiva en adultosmayores.